What is the Market Size for Deep Brain Stimulation ? : 

IMARC Group’s latest report, titled “Deep Brain Stimulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global deep brain stimulation market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.54% during 2023-2028

Deep brain stimulation (DBS) is an innovative surgical procedure used to treat a variety of neurological and movement-related disorders, such as Parkinson’s Disease, epilepsy, dystonia, and obsessive-compulsive disorder (OCD). It involves the implantation of electrodes in strategic regions of the brain to generate electrical signals that aid in controlling abnormal impulses in the brain. It utilizes a pacemaker-like device called a programmable generator, which is placed under the skin in the upper chest of the patient, and is connected to the electrodes through a wire. Additionally, it is thought to block the formation of neurological dysfunction, disrupt disruptive impulses, and promote more effective brain functioning. Moreover, it assists patients in managing tremors, stiffness, and dyskinesias without the need for large amounts of medication.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/deep-brain-stimulation-market/requestsample

Who are the Players in the Deep Brain Stimulation market ? :

The competitive landscape of the industry has also been examined along with the profiles of the key players being

  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Aleva Neurotherapeutics
  • Beijing Pins Medical
  • NeuroPace
  • Neuro Sigma

Deep Brain Stimulation Market Trends and Development:

The global market is driven by the rising prevalence of motor and neurological disorders among the masses. Along with this, the increasing acceptance of minimally invasive (MI) surgical techniques to reduce medical expenses, minimize post-operative scarring, and shorten hospital stays is contributing to the market. In addition, the development of numerous hospitals, nursing homes, and clinics to provide quality healthcare services to patients across the globe is another factor fuelling the market.

Moreover, the widespread integration of artificial intelligence (AI) and the internet of things (IoT) into DBS systems for robot-assisted implantations and multitarget stimulations is creating a favorable market outlook. Apart from this, the growing awareness of the benefits of DBS, early detection of neurological complications, and the rapidly aging population is further boosting the market.

Key Market Segmentation:

Breakup by Stimulation Type:

  • Subthalamic DBS
  • Globus Pallidus DBS
  • Thalamic DBS
  • Pedunculopontine Nucleus DBS


  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator 

by Application:

  • Parkinson’s Disease (PD)
  • Epilepsy
  • Dystonia
  • Obsessive Compulsive Disorder (OCD)
  • Others


  • Hospitals
  • Ambulatory Surgical Centers
  • Neurological Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other) 

Key Highlights of the Report: 

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape 

Report Coverage:

Report FeaturesDetails
Base Year of the Analysis2022
Historical Period2017-2022
Forecast Period2023-2028
UnitsUS$ Billion
Stimulation Types CoveredSubthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS
Products CoveredSingle Channel, Dual Channel
Applications Covered Parkinson’s Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), Others
End-Users CoveredHospitals, Ambulatory Surgical Centers, Neurological Centers, Others
Region CoveredAsia Pacific, North America, Europe, Middle East and Africa, Latin America
Companies CoveredBoston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace and Neuro Sigma
Customization Scope10% Free Customization
Report Price and Purchase OptionSingle User License: US$ 2499
Five User License: US$ 3499
 Corporate License: US$ 4499
Post-Sale Analyst Support10-12 Weeks
Delivery FormatPDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization. 

About Us: 

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:


134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.coms

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Read More: https://digitechindexing.com/

Leave a Reply

Your email address will not be published. Required fields are marked *